Atezolizumab-Induced Acrodermatitis and Pustular Psoriasis in a Patient with Non-Small Cell Lung Cancer: A Rare Case Report
Introduction: Immune checkpoint inhibitors are new drugs approved for the treatment of many types of malignancies. Despite their wide use and unquestionable clinical benefits, these agents have also been associated with a unique spectrum of side effects known as immune-related adverse events. In thi...
Saved in:
Main Authors: | Davide Fattore (Author), Gianluca Esposito (Author), Ludovica Carangelo (Author), Maria Antonietta Luciano (Author), Matteo Megna (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pustular psoriasis of pregnancy with acrodermatitis continua of hallopeau
by: Akanksha Shah, et al.
Published: (2016) -
Pustular psoriasis triggered by therapy with atezolizumab and bevacizumab
by: Mariani Magnus da Luz Andrade, et al.
Published: (2024) -
Acrodermatitis continua of hallopeau evolving into generalised pustular psoriasis
by: Poovanur SS Ranugha, et al.
Published: (2013) -
Acrodermatitis continua of Hallopeau and geographic tongue are variants of pustular psoriasis
by: Muriel Sadlier, MB, BMedSc, MRCPI
Published: (2018) -
Lingual Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Successfully Treated with Adalimumab: A Rare Case Report and Review of Oral Psoriasis
by: Sarah J.J. Touyz, et al.
Published: (2018)